SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Abstract Background Homologous recombination deficiency (HRD) is closely associated with patient prognosis and treatment options in prostate cancer (PCa). However, there is a lack of quantitative indicators related to HRD to predict the prognosis of PCa accurately. Methods We screened HRD-related ge...

Full description

Bibliographic Details
Main Authors: Cong Luo, Zhi Liu, Yu Gan, Xiaomei Gao, Xiongbing Zu, Ye Zhang, Wenrui Ye, Yi Cai
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Journal of Translational Medicine
Subjects:
Homologous recombination deficiency
Prostate cancer
SLC26A4
Prognosis
PARP inhibitors
Online Access:https://doi.org/10.1186/s12967-022-03513-5

Internet

https://doi.org/10.1186/s12967-022-03513-5

Similar Items